Wilms' Tumour
Some Pediatric Patients With Wilms' Tumor Can Avoid Doxorubicin
July 09, 2015Children with Wilm's tumor who are at low risk for relapse can be given less intensive treatment by omitting doxorubicin from the treatment regimen.
Chest radiation to treat childhood Wilms tumor increases breast cancer risk
November 10, 2014A new study has found that patients who received chest radiation for Wilms tumor may be more susceptible to breast cancer later in life, due to their radiation exposure.
Mutations in a gene essential for cell regulation cause kidney cancer in children
August 20, 2014Mutations in a gene that helps regulate when genes are switched on and off in cells have been found to cause rare cases of Wilms tumor, the most common kidney cancer occurring in children.
Colorectal risk defined for childhood cancer survivors
June 25, 2012Childhood cancer survivors may need earlier colorectal cancer screening, especially if abdominal radiation was part of their treatment.
Childhood cancer survivors more likely to have future GI problems
June 01, 2011People who underwent cancer therapy as children have a heightened risk of developing gastrointestinal (GI) complications later in life, a new study shows.
Doxorubicin
August 01, 2010Doxorubicin is an anthracycline antibiotic that is used to treat lymphoblastic and acute myeloblastic leukemias, several types of cancer, Kaposi sarcoma related to AIDS, malignant lymphoma, soft tissue and osteogenic sarcomas, and Wilms tumor.
Wilms' tumour: Assessing and managing nephroblastoma
January 22, 2010Reviews the clinical features and diagnosis of Wilm's tumor, as well as management and follow up
ONA Articles
- Sexual Dysfunction in Women With Cancer: A Review of Available Interventions
- Osteoporosis Medication Improves Bone Health in ADT-Treated Prostate Cancer
- Inotuzumab Ozogamicin Granted FDA Approval for Acute Lymphoblastic Leukemia
- Value of Type and Crossmatch Prior to Daratumumab Administration
- Cabazitaxel in Prostate Cancer: Reduced Dose Noninferior to Standard Dose
- To Better Serve Patients With Cancer, Navigators Need Better Systems
- Physical Activity Improves Cognitive Function for Breast Cancer Survivors
- Risk of Lung Cancer Increases With Diets Higher in Saturated Fats
- Mechanisms Identified for Curcumin Resensitization of Cancer Cells
- Value of Type and Crossmatch Prior to Daratumumab Administration
- Arthritis Medication Shows Potential in the Treatment of Polycythemia Vera
- Inotuzumab Ozogamicin Granted FDA Approval for Acute Lymphoblastic Leukemia
- Osteoporosis Medication Improves Bone Health in ADT-Treated Prostate Cancer
- Breast Conservation Improves Survival vs Mastectomy in Breast Cancer
- Cabazitaxel in Prostate Cancer: Reduced Dose Noninferior to Standard Dose
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
| Bone Cancer | Regimens | Drugs |
| Brain Cancer | Regimens | Drugs |
| Breast Cancer | Regimens | Drugs |
| Endocrine Cancer | Regimens | Drugs |
| Gastrointestinal Cancer | Regimens | Drugs |
| Genitourinary Cancer | Regimens | Drugs |
| Gynecologic Cancer | Regimens | Drugs |
| Head and Neck Cancer | Regimens | Drugs |
| Hematologic Cancer | Regimens | Drugs |
| Lung Cancer | Regimens | Drugs |
| Other Cancers | Regimens | |
| Rare Cancers | Regimens | |
| Skin Cancer | Regimens | Drugs |